Clinical Trials Sponsored by Triskelion, The Netherlands

Total 940 results

Erasmus Medical Center
Maastricht University Medical Center; Catharina Ziekenhuis Eindhoven; Medical... and other collaborators

Completed

The Permacol Dutch Cohort Study

Hernia of Abdominal Wall | Biologic Implant | Infected Hernioplasty Mesh

Netherlands
Medical Research Foundation, The Netherlands
Langerhans Foundation, the Netherlands

Completed

Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using Insulin

Diabetes Mellitus, Type 2

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer (DECIDE)

NSCLC
The Netherlands Cancer Institute

Recruiting

A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL (DESTINATION)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Chemosensitivity During Phases of the Menstrual Cycle in Breast Cancer Patients (Chemosense)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC (VULCANIZE-II)

Squamous Cell Carcinoma of the Vulva | Locally Advanced Vulvar Carcinoma

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Effect of a Bundle of Non-pharmacological Interventions on the Stress Response to Surgery (SPACU-lab)

Pain, Postoperative | Stress, Psychological | Stress, Physiological | Surgical Injury
The Netherlands Cancer Institute

Recruiting

FMT to Convert Response to Immunotherapy

Melanoma Stage IV | Melanoma Stage III

Netherlands
The Netherlands Cancer Institute

Recruiting

The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Blood Sampling of Healthy Volunteers for Immunological Research

Healthy Volunteers

Netherlands
The Netherlands Cancer Institute

Enrolling by invitation

The Food-effect on Alectinib Pharmacokinetics

NSCLC

Netherlands
The Netherlands Cancer Institute

Completed

Navigated Abdominal Lymph Node Dissections (N16LND)

Lymph Node Metastasis | Image-guide Surgery

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer (neo-TN)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Health-related Quality of Life and Late Effects Among SURVivors of Cancer in Adolescence and Young Adulthood: The SURVAYA Study

Quality of Life | Cancer | Lifestyle | Survivorship | Late Effect

Netherlands
The Netherlands Cancer Institute

Completed

Dose-Effect Relation of Salivary Gland Irradiation

HNSCC

Netherlands
The Netherlands Cancer Institute

Terminated

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Preoperative Breast Irradiation (PROBI)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm. (N12HYB)

Inoperable Locally Advanced Non Small Cell Lung Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Mapping of Sentinel Lymph Node Drainage Using SPECT (SUSPECT) (SUSPECT) (SUSPECT)

Head and Neck Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma

Melanoma | Skin Neoplasms

Netherlands
The Netherlands Cancer Institute

Withdrawn

Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLC (HYPOLAN)

Non-Small Cell Lung Cancer
The Netherlands Cancer Institute

Completed

Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer (PAPBI)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Study With Improved Solubility Pazopanib

Pharmacokinetics of Pazopanib

Netherlands
The Netherlands Cancer Institute

Completed

Trastuzumab in a Neo-adjuvant Regimen for HER2+ Breast Cancer - the TRAIN Study (TRAIN)

Breast Cancer | HER2 Positive

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma (MARIANE)

Melanoma

Netherlands
The Netherlands Cancer Institute

Recruiting

Image-guided Navigation During Robotic Sentinel Node Removal (N21LND)

Prostate Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer (CisCon)

Fallopian Tube Carcinoma | Peritoneal Cancer | FIGO Stage III Ovarian Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Improved Implant for Reconstruction Purposes After Mandibular Resection (RifRam)

Head and Neck Cancer | Oral Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

The Prospective Observational COMPRAYA Cohort Study (COMPRAYA)

Cancer | Fertility Issues | Genetic Disease | Lifestyle | Survivorship | Distress, Emotional | Second Cancer

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy (ASICS)

Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Sentinel Lymph Node
The Netherlands Cancer Institute

Recruiting

Multicentric Randomised Trial for Resectable Gastric Cancer (CRITICS-II)

Gastric Cancer

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer (Subito)

Breast Cancer

Netherlands, France
The Netherlands Cancer Institute

Completed

Tracked Ultrasound for Patient Registration in Surgical Navigation During Abdominal Cancer Surgery

Abdominal Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas (DOREMY)

Myxoid Liposarcoma of Soft Tissue

Netherlands, United Kingdom, Norway, United States, Denmark
The Netherlands Cancer Institute

Completed

Olaparib and Radiotherapy in Inoperable Breast Cancer

Locally Advanced Malignant Neoplasm | Triple-Negative Invasive Breast Carcinoma | Inflammatory Breast Carcinoma

Netherlands
The Netherlands Cancer Institute

Active, not recruiting

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Neuroendocrine Carcinomas

Netherlands
The Netherlands Cancer Institute

Terminated

Monitoring MRI Changes Before and During Radiotherapy Treatment of Brain Tumors

Brain Tumor

Netherlands
The Netherlands Cancer Institute

Completed

Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases

Meningeal Carcinomatosis

Netherlands
The Netherlands Cancer Institute

Terminated

Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F)

Cervical Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Adaptive Dose-Escalated Multi-modality Image-guided RadiothErapy (ADMIRE)

Head and Neck Cancer

Netherlands
The Netherlands Cancer Institute

Completed

Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines

Neoplasms

Netherlands
The Netherlands Cancer Institute

Completed

PET Response During Chemoradiation of Lung Cancer

NSCLC

Netherlands
The Netherlands Cancer Institute

Unknown

The Effectiveness of Patient Navigation in Cancer Care

Cancer

Netherlands
The Netherlands Cancer Institute

Terminated

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Unknown

Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer (DOP)

Prostatic Neoplasms

Netherlands
The Netherlands Cancer Institute

Completed

Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines

Neoplasms

Netherlands
Netherlands Heart Foundation
The Interuniversity Cardiology Institute of the Netherlands

Completed

Effect of NT-proBNP Guided Treatment of Chronic Heart Failure

Heart Failure, Congestive

Netherlands
The Netherlands Cancer Institute

Recruiting

Preoperative Accelerated Partial Breast Irradiation in Patients With Locally Recurrent or Second Primary Breast Cancer (PAPBI-3)

Breast Cancer

Netherlands
The Netherlands Cancer Institute

Recruiting

Peri-operative Slow-paced Breathing to Reduce Anxiety in Breast Cancer Surgery Patients (SlowPACE)

Anxiety

Netherlands
The Netherlands Cancer Institute

Not yet recruiting

LB-100 (PP2A Inhibitor) and Azenosertib (WEE1 Inhibitor) in Metastatic Colorectal Cancer Patients

Metastatic Colorectal Cancer

Clinical Trials Sponsored by Triskelion, The Netherlands

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations